Medico Remedies Share Price

  • 39.23-0.25 (-0.61%)
  • Volume: 42,384
  • Closed
  • Last Updated On: 08 Sep, 2025, 03:32 PM IST
Loading...
Medico Remedies Share Price
  • 39.23-0.25 (-0.61%)
  • Volume: 42,384
Advertisment

Medico Remedies share price insights

  • Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 4.16% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

  • Medico Remedies Ltd. share price moved down by -0.61% from its previous close of Rs 39.47. Medico Remedies Ltd. stock last traded price is 39.23

    Share PriceValue
    Today/Current/Last39.23
    Previous Day39.4739.22

InsightsMedico Remedies

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    31.51
    EPS - TTM
    (₹)
    1.25
    MCap
    (₹ Cr.)
    325.55
    Sectoral MCap Rank
    92
    PB Ratio
    (x)
    5.24
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    2.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-

    -
    VWAP
    (₹)
    39.43
    52W H/L
    (₹)
    79.83 / 37.18

    Medico Remedies Share Price Returns

    1 Day-0.61%
    1 Week-3.09%
    1 Month-0.13%
    3 Months-20.12%
    1 Year-14.48%
    3 Years90.9%
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Medico Remedies belongs to analysts' top-rated companies list?

    View Stock Screeners

    Medico Remedies Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Medico Remedies Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Medico Remedies Financials

    • Insights

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 4.16% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
      Quarterly | AnnualJun 2025Mar 2025Dec 2024Sep 2024Jun 2024
      Total Income38.9141.6040.9140.0331.09
      Total Income Growth (%)-6.461.672.2228.74-25.81
      Total Expenses36.1935.4037.1437.6828.74
      Total Expenses Growth (%)2.23-4.68-1.4431.12-23.19
      EBIT2.726.193.772.342.35
      EBIT Growth (%)-56.1664.0861.00-0.32-47.65
      Profit after Tax (PAT)1.824.342.621.551.58
      PAT Growth (%)-58.1265.7068.59-1.58-49.06
      EBIT Margin (%)6.9814.899.225.867.56
      Net Profit Margin (%)4.6710.446.403.885.08
      Basic EPS (₹)0.220.520.320.190.19
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue153.63147.05144.38123.05123.42
      Total Revenue Growth (%)4.481.8517.34-0.3036.02
      Total Expenses140.13135.71134.29116.50119.73
      Total Expenses Growth (%)3.251.0615.27-2.7035.26
      Profit after Tax (PAT)10.098.297.244.892.59
      PAT Growth (%)21.7414.4948.0988.6858.96
      Operating Profit Margin (%)9.718.387.725.913.76
      Net Profit Margin (%)6.685.725.154.042.11
      Basic EPS (₹)1.221.000.872.956.25

      All figures in Rs Cr, unless mentioned otherwise

      No reported Profit & Loss Statement are available.

    • Insights

      • Contingent Liabilities Coverage

        Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets119.8096.2087.4576.1975.62
      Total Assets Growth (%)24.5310.0114.780.750.46
      Total Liabilities57.3343.8243.6138.8743.16
      Total Liabilities Growth (%)30.830.4812.19-9.94-4.93
      Total Equity62.4752.3743.8437.3232.46
      Total Equity Growth (%)19.2919.4617.4714.978.67
      Current Ratio (x)1.701.721.551.551.54
      Total Debt to Equity (x)0.220.130.180.280.40
      Contingent Liabilities0.08-0.28--

      All figures in Rs Cr, unless mentioned otherwise

      No reported Balance Sheet are available.

    • Insights

      • Cash from Operations vs PAT

        Operating cash flow of Rs 4.89 cr is 0.48 times compared to the reported net profit of Rs 10.09 cr. (Source: Standalone Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities4.89-8.171.712.61
      Net Cash used in Investing Activities-3.46--6.60-2.86-0.08
      Net Cash flow from Financing Activities-0.52--1.827.40-0.35
      Net Cash Flow0.91--0.256.252.18
      Closing Cash & Cash Equivalent1.09-0.916.252.83
      Closing Cash & Cash Equivalent Growth (%)20.130.00-85.42120.82336.68
      Total Debt/ CFO (x)2.83-0.996.205.01

      All figures in Rs Cr, unless mentioned otherwise

      No reported Cash Flow Statement are available.

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)16.1515.8316.5113.107.98
      Return on Capital Employed (%)23.3322.7723.6118.6912.23
      Return on Assets (%)8.428.618.286.413.42
      Interest Coverage Ratio (x)15.2718.2618.1615.155.00
      Asset Turnover Ratio (x)1.401.581.721.59161.84
      Price to Earnings (x)42.9249.5086.2128.5716.03
      Price to Book (x)6.927.8114.143.741.28
      EV/EBITDA (x)25.1627.6346.1315.998.26
      EBITDA Margin (%)11.7210.379.667.635.11

      No reported Financial Ratios are available.

    Financial InsightsMedico Remedies

    • Income (P&L)
    • Balance Sheet
    • Cash Flow
      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 4.16% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

      • Contingent Liabilities Coverage

        Company has sufficient cash reserves to pay off its contingent liabilities. (Source: Standalone Financials)

      • Cash from Operations vs PAT

        Operating cash flow of Rs 4.89 cr is 0.48 times compared to the reported net profit of Rs 10.09 cr. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Medico Remedies Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Medico Remedies Peer Comparison

      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Medico Remedies31.515.2116.1523.338.427.609.716.681.221.700.222.83
      Albert David72.521.164.386.293.364.417.414.9730.143.400.03-0.35
      Brooks Labs-1,066.264.44-10.154.18-8.05-3.175.113.65-3.721.480.062.41
      Zim Laboratories39.001.454.829.612.574.397.753.202.501.390.442.73
      Lyka Labs47.013.377.7310.334.54-10.389.675.722.221.450.3619.40
      Add More
      Annual Ratios (%)

      Choose from Peers

      • SMS Lifesciences Ind
      • Nectar Lifesc
      • Bafna Pharma
      • Natural Capsule
      • Aarey Drugs

      Choose from Stocks

      Peers InsightsMedico Remedies

        Do you find these insights useful?

        • hate it

        • meh

        • love it

        Medico Remedies Shareholding Pattern

        • Loading...
          Showing Medico Remedies Shareholding as on Jun 2025
          CategoryJun 2025Mar 2025Dec 2024Sep 2024
          Promoters62.5963.7966.8373.34
          Pledge0.000.000.000.00
          FII0.070.110.380.22
          DII0.010.010.780.97
          Mutual Funds0.000.000.000.00
          Others37.3336.0932.0125.47
        • Showing Shareholding as on Jun 2025
          CategoryNo. of SharesPercentage% Change QoQ
          Promoters5,19,37,14562.59 %-1.19
          Pledge00.00 %0.00
          FII58,4990.07 %-0.04
          DII11,2790.01 %0.00
          Others3,09,77,07737.33 %1.23

        Medico Remedies MF Ownership

        MF Ownership details are not available.

        Medico Remedies Corporate Actions

        • Meeting DateAnnounced onPurposeDetails
          Sep 08, 2025Aug 05, 2025AGM-
          Aug 08, 2025Aug 01, 2025Board MeetingQuarterly Results
          May 08, 2025Apr 30, 2025Board MeetingAudited Results
          Feb 05, 2025Jan 30, 2025Board MeetingQuarterly Results
          Feb 01, 2025Dec 27, 2024POM-
        • Dividend announcements are not available.

        • All TypesEx-DateRecord DateAnnounced onDetails
          SplitsMar 16, 2023Mar 16, 2023Feb 02, 2023Split: Old FV10.0| New FV:2.0
          BonusNov 16, 2021Nov 17, 2021Oct 07, 2021Bonus Ratio: 3 share(s) for every 1 shares held

        About Medico Remedies

        Medico Remedies Ltd., incorporated in the year 1994, is a Small Cap company (having a market cap of Rs 327.54 Crore) operating in Pharmaceuticals sector. Medico Remedies Ltd. key Products/Revenue Segments include Drugs & Pharmaceuticals, Labour Charges and Other Operating Revenue for the year ending 31-Mar-2025. Show More

        • Executives

        • Auditors

        • HK

          Haresh Kapurlal Mehta

          Chairman & Wholetime Director
          HH

          Harshit Haresh Mehta

          Managing Director
          RH

          Rishit Haresh Mehta

          Whole Time Director
          RH

          Rita Haresh Mehta

          Non Executive Woman Director
          Show More
        • V J Shah & Co.

        FAQs about Medico Remedies share

        • 1. What is Medico Remedies share price and what are the returns for Medico Remedies share?
          Medico Remedies share price is Rs 39.23 as on 08 Sep, 2025, 03:59 PM IST. Medico Remedies share price is down by 0.61% based on previous share price of Rs 39.51. Medico Remedies share price trend:
          • Last 3 Months: Medico Remedies share price moved down by 20.12%
          • Last 12 Months: Medico Remedies share price moved down 14.48%
          • Last 3 Years: Medico Remedies Share price moved up by 90.90%
        • 2. What are the returns for Medico Remedies share?
          Return Performance of Medico Remedies Shares:
          • 1 Week: Medico Remedies share price moved down by 3.09%
          • 3 Month: Medico Remedies share price moved down by 20.12%
          • 6 Month: Medico Remedies share price moved down by 35.72%
        • 3. What is the PE & PB ratio of Medico Remedies?
          The PE ratio of Medico Remedies stands at 31.7, while the PB ratio is 5.24.
        • 4. What is the market cap of Medico Remedies?
          Medico Remedies share has a market capitalization of Rs 325.30 Cr. Within Pharmaceuticals sector, it's market cap rank is 92.
        • 5. What has been highest price of Medico Remedies share in last 52 weeks?
          Medico Remedies share price saw a 52 week high of Rs 79.83 and 52 week low of Rs 37.18.

        Trending in Markets

        Top Gainers As on 03:59 PM | 08 Sep 2025

        Suven Pharma 1,012.95
        90.06 (9.76%)
        Guj Mineral Dev.539.15
        30.15 (5.93%)
        Bharat Forge1,202.80
        66.10 (5.82%)
        Ashok Leyland137.29
        6.52 (4.99%)
        JP Power20.02
        0.95 (4.99%)

        Top Losers As on 03:57 PM | 08 Sep 2025

        Amber Enterprises7,473.00
        -320.50 (-4.12%)
        EID Parry1,067.30
        -45.50 (-4.09%)
        Trent5,315.50
        -213.00 (-3.86%)
        Godfrey Philips10,657.00
        -416.00 (-3.76%)
        Coromandel Int.2,185.20
        -72.71 (-3.22%)

        DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

        DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

        By using this site, you agree to the Terms of Service and Privacy Policy.

        The Economic Times